Technical Analysis for AGRX - Agile Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.56 3.13% 0.02
AGRX closed up 3.13 percent on Monday, March 18, 2024, on 47 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 20
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 3.13%
New 52 Week Closing Low Bearish 3.13%
Lower Bollinger Band Walk Weakness 3.13%
New 52 Week Low Weakness 3.13%
Wide Bands Range Expansion 3.13%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 14 hours ago
60 Minute Opening Range Breakout about 17 hours ago
Up 5% about 17 hours ago
Down 2 % about 18 hours ago
2x Volume Pace about 18 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a levonorgestrel-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Drugs Clinical Development Alcohol Organic Compounds Estrogen Transdermal Estranes Hormonal Contraception Medroxyprogesterone Acetate

Is AGRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.5
52 Week Low 0.5068
Average Volume 752,877
200-Day Moving Average 2.08
50-Day Moving Average 1.20
20-Day Moving Average 0.79
10-Day Moving Average 0.70
Average True Range 0.10
RSI (14) 20.00
ADX 30.17
+DI 16.17
-DI 33.54
Chandelier Exit (Long, 3 ATRs) 1.02
Chandelier Exit (Short, 3 ATRs) 0.80
Upper Bollinger Bands 1.04
Lower Bollinger Band 0.53
Percent B (%b) 0.06
BandWidth 64.82
MACD Line -0.18
MACD Signal Line -0.18
MACD Histogram -0.001
Fundamentals Value
Market Cap 1.66 Million
Num Shares 2.96 Million
EPS 7.31
Price-to-Earnings (P/E) Ratio 0.08
Price-to-Sales 0.18
Price-to-Book 1.79
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.63
Resistance 3 (R3) 0.63 0.61 0.62
Resistance 2 (R2) 0.61 0.59 0.61 0.62
Resistance 1 (R1) 0.58 0.58 0.57 0.58 0.61
Pivot Point 0.56 0.56 0.55 0.56 0.56
Support 1 (S1) 0.53 0.54 0.52 0.54 0.51
Support 2 (S2) 0.51 0.53 0.51 0.50
Support 3 (S3) 0.48 0.51 0.50
Support 4 (S4) 0.49